PharmaResources (Shanghai) Co. Ltd. A (301230) — Free Cash Flow Generation Index

Latest as of December 2025: 0.68x

PharmaResources (Shanghai) Co. Ltd. A (301230) has a Free Cash Flow Generation Index of 0.68x as of December 2025. Free cash flow of CN¥92.20 Million represents 1% of operating cash flow (CN¥135.51 Million). Read PharmaResources (Shanghai) Co. Ltd. A debt and liabilities for a breakdown of total debt and financial obligations.

FCF Generation Index

0.68x
Free Cash Flow / Operating CF

Free Cash Flow

CN¥92.20 Million
CNY

Operating Cash Flow

CN¥135.51 Million
CNY

Capital Expenditures

CN¥43.32 Million
CNY

PharmaResources (Shanghai) Co. Ltd. A Free Cash Flow Generation Index (2020–2025)

Historical FCF Generation Index trend for PharmaResources (Shanghai) Co. Ltd. A across 6 annual periods. Explore PharmaResources (Shanghai) Co. Ltd. A (301230) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.

Annual Free Cash Flow Generation for PharmaResources (Shanghai) Co. Ltd. A (2020–2025)

Year-by-year Free Cash Flow Generation Index for PharmaResources (Shanghai) Co. Ltd. A. For the full company profile including market capitalisation, see PharmaResources (Shanghai) Co. Ltd. A stock valuation.

Year FCG Index Free Cash Flow (CNY) Operating CF Capital Expenditures YoY Change
2025 0.68x CN¥92.20 Million CN¥135.51 Million CN¥43.32 Million ▲ +292.8%
2024 -0.35x CN¥-28.54 Million CN¥80.86 Million CN¥109.40 Million ▲ +96.8%
2023 -10.90x CN¥-227.41 Million CN¥20.86 Million CN¥248.27 Million ▼ -4288.0%
2022 -0.25x CN¥-24.67 Million CN¥99.29 Million CN¥123.97 Million ▼ -300.8%
2021 0.12x CN¥13.01 Million CN¥105.12 Million CN¥92.12 Million ▼ -67.8%
2020 0.38x CN¥20.94 Million CN¥54.45 Million CN¥33.51 Million
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).